The effect of CD47 modified polymer surfaces on inflammatory cell attachment and activation. - Wikidata - awgldk - TriplyDB

The effect of CD47 modified polymer surfaces on inflammatory cell attachment and activation.

The effect of CD47 modified polymer surfaces on inflammatory cell attachment and activation.

http://www.wikidata.org/entity/Q35024822

about

Interplay between Cellular and Molecular Inflammatory Mediators in Lung Cancer Vascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigm Biodegradable poly(ester urethane)urea elastomers with variable amino content for subsequent functionalization with phosphorylcholine.The use of the ex vivo Chandler Loop Apparatus to assess the biocompatibility of modified polymeric blood conduits.CD47 Enhances In Vivo Functionality of Artificial Antigen-Presenting Cells Diminished adhesion and activation of platelets and neutrophils with CD47 functionalized blood contacting surfaces.Challenges in design and characterization of ligand-targeted drug delivery systems.Correlating macrophage morphology and cytokine production resulting from biomaterial contact.CD47-retargeted oncolytic adenovirus armed with melanoma differentiation-associated gene-7/interleukin-24 suppresses in vivo leukemia cell growth Hyaluronan and dextran modified tubes resist cellular activation with blood contact.'Marker-of-self' functionalization of nanoscale particles through a top-down cellular membrane coating approach.The use of CD47-modified biomaterials to mitigate the immune response.Intracellular signaling mechanisms associated with CD47 modified surfaces.Hemocompatibility of Chitosan/poly(acrylic acid) Grafted Polyurethane Tubing.Liposome-like Nanostructures for Drug Delivery.Strategies for delivery of therapeutics into the central nervous system for treatment of lysosomal storage disorders.Polymeric nanotherapeutics: clinical development and advances in stealth functionalization strategies.Receptor-targeted drug delivery: current perspective and challenges.Addressing the Inflammatory Response to Clinically Relevant Polymers by Manipulating the Host Response Using ITIM Domain-Containing Receptors.Minimal "Self" peptides that inhibit phagocytic clearance and enhance delivery of nanoparticles Enhanced biocompatibility of CD47-functionalized vascular stents.CD47 on artificial structures.Incorporation of a Ligand Peptide for Immune Inhibitory Receptor LAIR-1 on Biomaterial Surfaces Inhibits Macrophage Inflammatory Responses.Co-coating of receptor-targeted drug nanocarriers with anti-phagocytic moieties enhances specific tissue uptake versus non-specific phagocytic clearance.Modulation of Immune Responses by Particulate Materials.Stabilization of dry protein coatings with compatible solutes

P2860

Q26768652-D41D1438-0E2B-4137-999D-1E44C9D4A7A0 Q27026630-3F688E99-3BA3-49B9-ACE1-269C248308E0 Q30843340-20802213-0033-4484-B8EB-D9CE23E8CDCA Q35076985-F2700D66-FDC7-4E58-BBFA-C363A34C1FDD Q35563107-5D37AAA0-A30E-473A-B0E1-CCA5A5376396 Q36010745-00D9F95D-9B77-4998-99B2-15EA230C5717 Q36346851-B16C5F31-8B8F-4CBB-91B3-9E3BE5D2F544 Q36368434-4557B485-EE3F-483F-A76A-1EC0E7E2DD54 Q36685435-AE9C13DA-6140-4F2A-AE46-DF34AD926806 Q36823910-A1F4D320-67C6-43B4-998A-AF964685F711 Q36886925-107DF101-B386-4037-B430-A4EF182B6F61 Q37107151-F69A4746-E0F3-4538-BA43-FDEEBF5F2F8C Q37244592-7CC39EEB-0A15-44F8-82DD-54E576672B3E Q37384143-AA481C67-4982-4D00-9E22-4970F232CB22 Q37424654-A752F5BF-C04F-4FF2-86D3-ECA10E5603E2 Q37672410-4E82EF30-E0C1-4921-BF15-536F065825B8 Q38166550-6181901D-9A40-4956-9E42-2154CA5AD799 Q38265617-C4F81191-C98D-4BE7-B50E-AF3A5AE4B24B Q38364218-DCF813BB-76FC-4819-A864-7844BD19D291 Q38525935-081DA331-7E92-41AE-AA6A-B544B6519175 Q38791109-6EF2683D-0844-4C3F-8D75-07D4B2FA5035 Q43237766-99303C78-E73E-4AE5-94CF-557B76CD9E35 Q46073757-7B778A69-D739-4C8F-B1D3-76D4DA3B905B Q47782730-1985A474-B474-4A1F-A1D2-51EC7FDB1B2B Q51336724-05CA72D1-4844-4DFE-99F6-FD6EE6657EA8 Q57092005-01B7C358-965D-46E2-8DBE-5F1D52295620

P2860

The effect of CD47 modified polymer surfaces on inflammatory cell attachment and activation.

http://www.wikidata.org/entity/Q35024822

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

The effect of CD47 modified po ...... ell attachment and activation.

@ast

The effect of CD47 modified po ...... ell attachment and activation.

@en

type

label

The effect of CD47 modified po ...... ell attachment and activation.

@ast

The effect of CD47 modified po ...... ell attachment and activation.

@en

prefLabel

The effect of CD47 modified po ...... ell attachment and activation.

@ast

The effect of CD47 modified po ...... ell attachment and activation.

@en

P1433

Q35024822-6574D189-7227-49B7-931D-FD3E7987BC80

P1476

Q35024822-AF83320D-9F05-46C3-80F0-F3665E9004DA

P2093

Q35024822-2CE056F3-3821-4EAE-968D-9902943E0252

Q35024822-33ED4BCF-00A9-4653-B933-11AC4E8D870A

Q35024822-363AE4ED-2DBE-446A-9E81-0ED40F27E472

Q35024822-53B72478-B3EE-4C2B-943F-1CA22D12521B

Q35024822-78AB40E8-2938-409C-AAD8-AE0C86E88DA0

Q35024822-A6229580-C63A-4523-AA71-D829FD22BFF3

Q35024822-B7DEA529-EBA3-4363-9348-43E565A720F6

Q35024822-D40FCD25-4519-48F2-8A8E-A7CDFBE82E92

Q35024822-E1AF843F-F524-4FD6-85B9-407DFB73D2FF

Q35024822-E9B68071-91B3-4961-AFC8-547CF43FC46F

P2860

Q35024822-021F80F2-74CC-46FC-ADDD-A0C3B87F2346

Q35024822-1442B69B-89ED-4C62-80D7-236971076F7A

Q35024822-200720A0-746E-45CC-BDB0-C2C94B5F63C5

Q35024822-22026689-0DF5-4F9C-87EF-D079F000B7A1

Q35024822-2DF74AF9-6603-4526-98AE-2C3E567ADD9D

Q35024822-331DA19A-CFC5-43AF-8EDE-CF7ADAE00A91

Q35024822-39221ABE-AD69-42F2-A996-16DBC7B853A7

Q35024822-415B7AAD-2237-41B4-B68A-D93ED4AB0F95

Q35024822-600827E7-A52F-424C-8FDB-7CA87AB1BB37

Q35024822-7F0F09A8-F82F-4C3A-A8F8-4118971A9352

P304

Q35024822-A3228D41-4E38-4962-A383-DFB304F3A6C2

P31

Q35024822-7D84319C-118E-472D-AA72-D5ABCA5B9B09

P356

Q35024822-2A8AEBCD-4716-4BCF-B110-F4CACCEEF5EA

P433

Q35024822-B2685EF2-E494-4AE7-A7EA-81003707864F

P478

Q35024822-EC74434C-DE0B-4A9A-BA48-A5510A791022

P577

Q35024822-58B90D1D-55C3-41BF-BD14-43118DF343BF

P5875

Q35024822-B23D1033-12E8-4FD2-8D3D-D7BC6FCA9387

P698

Q35024822-A8C81893-C9C5-42A7-BEB3-6600F936BF64

P932

Q35024822-038865AE-1644-4CEE-8F6F-E3C5A2690145

P356

J.BIOMATERIALS.2011.02.053

P1433

P1476

The effect of CD47 modified po ...... ell attachment and activation.

@en

P2093

David M Eckmann

http://www.w3.org/2001/XMLSchema#string

Dennis E Discher

http://www.w3.org/2001/XMLSchema#string

Edward C Eckells

http://www.w3.org/2001/XMLSchema#string

Fengxiang Wang

http://www.w3.org/2001/XMLSchema#string

Ivan S Alferiev

http://www.w3.org/2001/XMLSchema#string

Jeanne M Connolly

http://www.w3.org/2001/XMLSchema#string

Matthew J Finley

http://www.w3.org/2001/XMLSchema#string

Nancy Tomczyk

http://www.w3.org/2001/XMLSchema#string

Richard K Tsai

http://www.w3.org/2001/XMLSchema#string

Robert J Levy

http://www.w3.org/2001/XMLSchema#string

P2860

CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis

Cleavage of structural proteins during the assembly of the head of bacteriophage T4

Role of CD47 as a marker of self on red blood cells

Integrin-associated protein (CD47) and its ligands

Role of CD47 in erythroid cells and in autoimmunity

Target cell CD47 regulates macrophage activation and erythrophagocytosis.

Leukocyte-epithelial interactions.

Immune inhibitory receptors.

Myxoma virus M128L is expressed as a cell surface CD47-like virulence factor that contributes to the downregulation of macrophage activation in vivo.

Inhibition of "self" engulfment through deactivation of myosin-II at the phagocytic synapse between human cells.

P304

4317-4326

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BIOMATERIALS.2011.02.053

http://www.w3.org/2001/XMLSchema#string

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50830963

http://www.w3.org/2001/XMLSchema#string

P698

21429575

http://www.w3.org/2001/XMLSchema#string

P932

3108143

http://www.w3.org/2001/XMLSchema#string